Why is Aurinia Pharmaceuticals (AUPH) Underperforming This Year?

Over the course of the past week or so, the Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) stock has been in consolidation mode. This period has come about after the stock had tanked by as low as 30% last month.

A phase of consolidation can often lead to a breakout and hence, it might be a good idea to take a closer look at the company. In this regard, it is important for investors to note that the company is all set to be participants in two important investor conferences.

Related:  Drastically Soaring Stock Alert: Rising BioSciences (OTC: RBII)

One of those is the H.C. Wainwright Global Life Sciences Conference to be held on March 9. The other one is a presentation at Oppenheimer’s 31st Annual Healthcare Conference on March 17. The Aurinia management team could provide some key insights into the company’s business at these events and hence, it might be a good idea to keep a close eye on the proceedings.

Asan Abdiev

CEO and Editor in Chief. Living in the era of dynamic tech change Asan decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring Finance) writing for technology and as well as finance has been one of the precious aspects of his life